Clinical Advances and Therapeutic Challenges in Small-Cell Lung Cancer and Rare Thoracic Cancers
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Thoracic Oncology".
Deadline for manuscript submissions: 20 March 2026 | Viewed by 469
Special Issue Editor
Interests: thymoma; thymic epithelial tumor; thymus neoplasms; lung cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The clinical decision-making process for patients with rare tumors poses a significant challenge in oncology, particularly in defining individualized therapeutic strategies.
Unlike common malignancies, the available evidence and literature on rare tumors are predominantly limited to case series, retrospective studies, and small phase II prospective trials. Randomized trials, which are usually the cornerstone of therapeutic paradigms, are frequently unavailable or constrained by a limited sample size and the heterogeneity of enrolled populations.
Given this context, therapeutic decisions are largely based on physicians’ experience, guidelines developed by expert panels, and extrapolations from available evidence derived from different disease settings.
This Special Issue is dedicated to small-cell lung cancer and rare thoracic tumors, with a particular focus on epithelial thymic tumors, thoracic neuroendocrine neoplasms, and pleural mesothelioma.
Through meticulously analyzed and thoughtfully contextualized perspectives, this edition of Current Oncology aims to provide readers with valuable insights and updates on the latest clinical research developments, helping them navigate the intricate landscape of therapeutic decision-making.
I look forward to receiving your contributions.
Prof. Dr. Tommaso Martino De Pas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pleural mesothelioma
- thymic cancer
- neuroendocrine thoracic tumors
- small-cell lung cancer
- rare tumors
- thoracic cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
